Skip to main content
. 2022 Sep 2;19(17):10975. doi: 10.3390/ijerph191710975
BT-A onabotulinumtoxinA
CGRP calcitonin gene-related peptide
CM chronic migraine
CSD cortical spreading depression
HIT-6 6 items headache impact test
ICHD-3 International Classification of Headache Disorders 3rd edition
mAbs monoclonal antibodies
MIDAS Migraine Disability Assessment Questionnaire
MHDs the mean number of monthly headache days in the last 3 months
MDs the mean number of days per month in which patient took at least one medication (MDs) in the last 3 months
MO medication overuse
PREEMPT Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy
ROC Receiving Operating Characteristic
SD standard deviation